IRIS
IASEVOLI, FELICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.720
AS - Asia 6.682
EU - Europa 4.384
SA - Sud America 876
Continente sconosciuto - Info sul continente non disponibili 362
AF - Africa 181
OC - Oceania 6
Totale 19.211
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.421
SG - Singapore 2.798
RU - Federazione Russa 1.841
CN - Cina 1.396
VN - Vietnam 1.192
IT - Italia 1.095
BR - Brasile 708
HK - Hong Kong 499
DE - Germania 300
FR - Francia 215
BD - Bangladesh 207
FI - Finlandia 165
CA - Canada 160
NL - Olanda 142
GB - Regno Unito 138
IE - Irlanda 106
JP - Giappone 98
SE - Svezia 97
IN - India 79
UA - Ucraina 75
KR - Corea 73
AR - Argentina 67
MX - Messico 67
CI - Costa d'Avorio 62
ZA - Sudafrica 42
ES - Italia 39
IQ - Iraq 38
PL - Polonia 36
TH - Thailandia 36
ID - Indonesia 35
PH - Filippine 33
AT - Austria 30
PK - Pakistan 30
TR - Turchia 29
CO - Colombia 26
EC - Ecuador 23
TW - Taiwan 21
AE - Emirati Arabi Uniti 17
HU - Ungheria 17
JM - Giamaica 16
VE - Venezuela 16
CL - Cile 15
MA - Marocco 15
IS - Islanda 11
MY - Malesia 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
BE - Belgio 10
EG - Egitto 10
IR - Iran 10
KE - Kenya 10
PY - Paraguay 10
ET - Etiopia 9
HN - Honduras 9
CR - Costa Rica 8
LT - Lituania 8
RO - Romania 8
DO - Repubblica Dominicana 7
LB - Libano 7
BG - Bulgaria 6
JO - Giordania 6
NI - Nicaragua 6
OM - Oman 6
SI - Slovenia 6
AL - Albania 5
DZ - Algeria 5
NP - Nepal 5
TN - Tunisia 5
BS - Bahamas 4
CZ - Repubblica Ceca 4
GE - Georgia 4
GR - Grecia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PE - Perù 4
PR - Porto Rico 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AU - Australia 3
BY - Bielorussia 3
GA - Gabon 3
IL - Israele 3
LA - Repubblica Popolare Democratica del Laos 3
MK - Macedonia 3
MN - Mongolia 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BJ - Benin 2
BW - Botswana 2
CH - Svizzera 2
EE - Estonia 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
Totale 18.810
Salva come PNG Salva come JPEG
Città #
San Jose 1.318
Singapore 1.317
Hong Kong 468
Ashburn 445
Moscow 444
Beijing 401
Chandler 357
Ho Chi Minh City 318
Hefei 275
Hanoi 262
Santa Clara 239
Naples 224
Council Bluffs 206
Los Angeles 154
Millbury 146
Lauterbourg 136
The Dalles 118
New York 108
Amsterdam 104
Princeton 104
Munich 92
Dallas 89
Dong Ket 89
Nanjing 88
Rome 87
Tokyo 81
Buffalo 76
Wilmington 76
Jacksonville 73
Des Moines 72
Redondo Beach 70
Phoenix 69
São Paulo 68
Napoli 63
Da Nang 58
Boston 56
Seattle 56
Frankfurt am Main 55
Milan 50
Seoul 49
Turku 45
Norwalk 44
Haiphong 43
Chicago 42
Houston 40
Atlanta 38
Helsinki 37
Montreal 37
Brooklyn 36
Ottawa 34
San Francisco 33
Nanchang 32
Nuremberg 32
Orem 31
Shenyang 28
Toronto 28
Falkenstein 27
London 27
Mexico City 27
Denver 23
Rio de Janeiro 22
Catania 21
Johannesburg 21
Biên Hòa 20
Changsha 20
Baghdad 19
Jiaxing 19
Warsaw 18
Bangkok 17
Hebei 17
Hải Dương 17
Lawrence 17
Boardman 15
Can Tho 15
Stockholm 15
Barcelona 14
Belo Horizonte 14
Dublin 14
Woodbridge 14
Curitiba 13
Dhaka 13
Poplar 13
Tianjin 13
Bari 12
Charlotte 12
Chennai 12
Düsseldorf 12
Lappeenranta 12
Brasília 11
Falls Church 11
Kingston 10
Miami 10
Nairobi 10
Newark 10
Reykjavík 10
Shanghai 10
Vienna 10
Addis Ababa 9
Bogotá 9
Brussels 9
Totale 9.805
Salva come PNG Salva come JPEG
Nome #
Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis “Nutra NMA SCZ” 592
Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal 289
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study 227
D-aspartate dysregulation in Ddo-/- mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum 205
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 202
The effects of sustained COVID-19 emergency and restrictions on the mental health of subjects with serious mental illness: A prospective study 187
Psychological distress in serious mental illness patients during the COVID-19 outbreak and one-month mass quarantine in Italy 179
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 175
Regulation of postsynaptic plasticity genes' expression and topography by sustained dopamine perturbation and modulation by acute memantine: Relevance to schizophrenia 173
Altered Patterns of Brain Glucose Metabolism Involve More Extensive and Discrete Cortical Areas in Treatment-resistant Schizophrenia Patients Compared to Responder Patients and Controls: Results From a Head-to-Head 2-[18F]-FDG-PET Study 172
M170. GENETIC CHARACTERIZATION OF A COHORT OF PATIENTS AFFECTED BY SCHIZOPHRENIA. THE ROLE FOR RARE STRUCTURAL VARIANTS IN MODULATING TREATMENT RESISTANT ENDOPHENOTYPES: PRELIMINARY DATA 171
Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations 169
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice 166
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 165
Atypical depression and emotion dysregulation: Clinical and psychopathological features 162
Neuropsychiatric disorders in Cushing's syndrome. 159
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs 157
Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia 155
The relationship between emotional regulation and eating behaviour: a multidimensional analysis of obesity psychopathology 152
Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling 149
Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia 148
Corrigendum to “Exploring clinical phenotypes of food addiction and its distress correlates: A cross-sectional evaluation in treatment-seeking individuals with obesity” [Eating Behaviors volume 57 (April 2025), Online ahead of print, 101961] 146
Cerebellar transcranial direct current stimulation in children with autism spectrum disorder: A pilot study on efficacy, feasibility, safety, and unexpected outcomes in tic disorder and epilepsy 146
Neural substrates of verbal memory impairment in schizophrenia: A multimodal connectomics study 145
Transcranial direct current stimulation for bipolar depression: systematic reviews of clinical evidence and biological underpinnings 143
Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance 141
Depression and Anxiety Symptoms "Among the Waves" of the COVID-19 Pandemic in Obsessive Compulsive Disorder and Adjustment Disorder Patients 140
Addressing brain metabolic connectivity in treatment-resistant schizophrenia: a novel graph theory-driven application of 18F-FDG-PET with antipsychotic dose correction 140
Psychiatric Symptoms in Parkinson’s Disease Patients before and One Year after Subthalamic Nucleus Deep Brain Stimulation Therapy: Role of Lead Positioning and Not of Total Electrical Energy Delivered 139
Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review 138
The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment 137
The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis 136
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones 136
Estimating Multimodal Structural Brain Variability in Schizophrenia Spectrum Disorders: A Worldwide ENIGMA Study 136
The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes 135
Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches. 135
Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats 135
May second generation long-acting injectable antipsychotics be prescribed as a first-line treatment of first episode in patients with schizophrenia? An overview. 132
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia 132
Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders 131
Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients 131
Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action 130
The Role of Astrocytes in the Molecular Pathophysiology of Schizophrenia: Between Neurodevelopment and Neurodegeneration 130
The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials 129
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 128
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies beyond Dopamine Receptor Antagonism 128
Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants 128
Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients 128
Perinatal stress modulates glutamatergic functional connectivity: A post-synaptic density immediate early gene-based network analysis 127
Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis 127
Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment 127
Immediate-early genes modulation by antipsychotics: Translational implications for a putative gateway to drug-induced long-term brain changes 127
Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review 126
The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted 126
Decreased free D-aspartate levels in the blood serum of patients with schizophrenia 125
Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: Translational inference from a postsynaptic density immediate-early gene-based network analysis 125
Severity of autism-related symptoms in treatment-resistant schizophrenia: associations with cognitive performance, psychosocial functioning, and neurological soft signs - Clinical evidence and ROC analysis 125
MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective 125
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses 125
Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia 125
Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia 124
Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression 124
Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients 123
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. 122
Psychopathological Dimensions in Eating Disorders (E. D.) 121
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables 120
The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular “Lego” in the pathophysiology of psychiatric disorders. A systematic review and translational insight 120
Residual effects of medications for sleep disorders on driving performance: A systematic review and network meta-analysis of randomized controlled trials 119
Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes. 119
Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment 119
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 118
CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation 118
The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia 117
Alexithymia, suicidal ideation, and serum lipid levels among drug-na?ve outpatients with obsessive-compulsive disorder 117
Glutamatergic postsynaptic density in early life stress programming: Topographic gene expression of mGlu5 receptors and Homer proteins 117
Effects of strict COVID-19 lockdown on patients with obsessive-compulsive disorder compared to a clinical and a nonclinical sample 117
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 116
Scaffolding Proteins of the Post-synaptic Density Contribute to Synaptic Plasticity by Regulating Receptor Localization and Distribution: Relevance for Neuropsychiatric Diseases 115
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions 115
Neurostructural subgroup in 4291 individuals with schizophrenia identified using the subtype and stage inference algorithm 114
Dopamine receptor subtypes contribution to Homer1a induction: Insights into antipsychotic molecular action 114
The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders 114
Differential Adaptive Changes in Dopaminergic System by Acute vs. Subchronic Ketamine: Relevance for Psychosis Pathophysiology and Treatment 114
Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients 113
Fisiopatologia cellulare e molecolare 113
Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder 112
Pharmacological treatments for atypical depression: A systematic review and network meta-analysis of randomized controlled trials 111
Obsessive-Compulsive Aspects and Pathological Gambling in an Italian Sample 110
Ketamine-related expression of glutamatergic postsynaptic density genes: possible implications in psychosis 110
Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews 110
Striatal expression of Homer1a is affected by genotype but not dystonic phenotype of tottering mice: a model of spontaneously occurring motor disturbances 109
Predictors of Treatment Resistance Across Different Clinical Subtypes of Depression: Comparison of Unipolar vs. Bipolar Cases 108
Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia 108
S-Adenosyl-L-Methionine augmentation in patients with stage II treatment-resistant major depressive disorder: an open label, fixed dose, single-blind study. 107
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 107
Cariprazine (RGH-188): A new pharmacological target option for the treatment of schizophrenia, bipolar disorders and depression? 107
Exploring clinical phenotypes of food addiction and its distress correlates: A cross-sectional evaluation in treatment-seeking individuals with obesity 105
Predicting the Severity of Lockdown-Induced Psychiatric Symptoms with Machine Learning 105
C-reactive protein level and its relationship with suicide risk and alexithymia among newly diagnosed, drug-naïve patients with non-affective psychosis 105
Efficacia e sicurezza dell’asenapina in pazienti con episodi maniacali e misti associati a disturbo bipolare I 105
Totale 13.881
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.825
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022696 0 0 5 15 9 53 12 30 116 71 102 283
2022/2023891 129 70 26 56 113 132 5 88 130 71 57 14
2023/2024612 30 126 54 50 29 28 27 81 20 19 95 53
2024/20254.310 194 252 9 48 122 224 487 307 260 454 1.503 450
2025/20269.670 976 722 989 700 1.567 358 1.144 508 1.192 659 434 421
2026/20271.543 323 682 538 0 0 0 0 0 0 0 0 0
Totale 19.211